| |
| |
| |
| |
| |
| | | | |
|
PR:P05155 | plasma protease C1 inhibitor (human) | | | | | |
| | | | | |
|
PR:000053466 | plasma protease C1 inhibitor N-glycosylated 1 (human) | | | | | |
| | | | | |
|
PR:000053475 | plasma protease C1 inhibitor N-glycosylated 10 (human) | | | | | |
| | | | | |
|
PR:000053476 | plasma protease C1 inhibitor N-glycosylated 11 (human) | | | | | |
| | | | | |
|
PR:000053477 | plasma protease C1 inhibitor N-glycosylated 12 (human) | | | | | |
| | | | | |
|
PR:000053478 | plasma protease C1 inhibitor N-glycosylated 13 (human) | | | | | |
| | | | | |
|
PR:000053479 | plasma protease C1 inhibitor N-glycosylated 14 (human) | | | | | |
| | | | | |
|
PR:000053480 | plasma protease C1 inhibitor N-glycosylated 15 (human) | | | | | |
| | | | | |
|
PR:000053481 | plasma protease C1 inhibitor N-glycosylated 16 (human) | | | | | |
| | | | | |
|
PR:000053482 | plasma protease C1 inhibitor N-glycosylated 17 (human) | | | | | |
| | | | | |
|
PR:000053483 | plasma protease C1 inhibitor N-glycosylated 18 (human) | | | | | |
| | | | | |
|
PR:000053484 | plasma protease C1 inhibitor N-glycosylated 19 (human) | | | | | |
| | | | | |
|
PR:000053467 | plasma protease C1 inhibitor N-glycosylated 2 (human) | | | | | |
| | | | | |
|
PR:000053485 | plasma protease C1 inhibitor N-glycosylated 20 (human) | | | | | |
| | | | | |
|
PR:000053486 | plasma protease C1 inhibitor N-glycosylated 21 (human) | | | | | |
| | | | | |
|
PR:000053487 | plasma protease C1 inhibitor N-glycosylated 22 (human) | | | | | |
| | | | | |
|
PR:000053488 | plasma protease C1 inhibitor N-glycosylated 23 (human) | | | | | |
| | | | | |
|
PR:000053468 | plasma protease C1 inhibitor N-glycosylated 3 (human) | | | | | |
| | | | | |
|
PR:000053469 | plasma protease C1 inhibitor N-glycosylated 4 (human) | | | | | |
| | | | | |
|
PR:000053470 | plasma protease C1 inhibitor N-glycosylated 5 (human) | | | | | |
| | | | | |
|
PR:000053471 | plasma protease C1 inhibitor N-glycosylated 6 (human) | | | | | |
| | | | | |
|
PR:000053472 | plasma protease C1 inhibitor N-glycosylated 7 (human) | | | | | |
| | | | | |
|
PR:000053473 | plasma protease C1 inhibitor N-glycosylated 8 (human) | | | | | |
| | | | | |
|
PR:000053474 | plasma protease C1 inhibitor N-glycosylated 9 (human) | | | | | |
| | | | | |
|
PR:000053489 | plasma protease C1 inhibitor O-glycosylated 1 (human) | | | | | |
| | | | | |
|
PR:000053498 | plasma protease C1 inhibitor O-glycosylated 10 (human) | | | | | |
| | | | | |
|
PR:000053499 | plasma protease C1 inhibitor O-glycosylated 11 (human) | | | | | |
| | | | | |
|
PR:000053500 | plasma protease C1 inhibitor O-glycosylated 12 (human) | | | | | |
| | | | | |
|
PR:000053501 | plasma protease C1 inhibitor O-glycosylated 13 (human) | | | | | |
| | | | | |
|
PR:000053502 | plasma protease C1 inhibitor O-glycosylated 14 (human) | | | | | |
| | | | | |
|
PR:000053503 | plasma protease C1 inhibitor O-glycosylated 15 (human) | | | | | |
| | | | | |
|
PR:000053504 | plasma protease C1 inhibitor O-glycosylated 16 (human) | | | | | |
| | | | | |
|
PR:000053505 | plasma protease C1 inhibitor O-glycosylated 17 (human) | | | | | |
| | | | | |
|
PR:000053490 | plasma protease C1 inhibitor O-glycosylated 2 (human) | | | | | |
| | | | | |
|
PR:000053491 | plasma protease C1 inhibitor O-glycosylated 3 (human) | | | | | |
| | | | | |
|
PR:000053492 | plasma protease C1 inhibitor O-glycosylated 4 (human) | | | | | |
| | | | | |
|
PR:000053493 | plasma protease C1 inhibitor O-glycosylated 5 (human) | | | | | |
| | | | | |
|
PR:000053494 | plasma protease C1 inhibitor O-glycosylated 6 (human) | | | | | |
| | | | | |
|
PR:000053495 | plasma protease C1 inhibitor O-glycosylated 7 (human) | | | | | |
| | | | | |
|
PR:000053496 | plasma protease C1 inhibitor O-glycosylated 8 (human) | | | | | |
| | | | | |
|
PR:000053497 | plasma protease C1 inhibitor O-glycosylated 9 (human) | | | | | |
| | | | | |
|
PR:000070326 | plasma protease C1 inhibitor deaminated 1 (human) | | | | | |
| | | | | |
|
PR:P05155-1 | plasma protease C1 inhibitor isoform h1 (human) | | | | | |
| | | | | |
|
PR:P05155-2 | plasma protease C1 inhibitor isoform h2 (human) | | | | | |
| | | | | |
|
PR:P05155-3 | plasma protease C1 inhibitor isoform h3 (human) | | | | | |
| | | | | |
|
PR:000060408 | plasma protease C1 inhibitor sequence variant A456E, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000062279 | plasma protease C1 inhibitor sequence variant A458T, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061318 | plasma protease C1 inhibitor sequence variant A458V, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000060778 | plasma protease C1 inhibitor sequence variant F225*, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061855 | plasma protease C1 inhibitor sequence variant F236S, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000064313 | plasma protease C1 inhibitor sequence variant G184E, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061662 | plasma protease C1 inhibitor sequence variant G184R, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000062550 | plasma protease C1 inhibitor sequence variant G345R, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000064158 | plasma protease C1 inhibitor sequence variant G493E, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061229 | plasma protease C1 inhibitor sequence variant G493R, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061510 | plasma protease C1 inhibitor sequence variant I196N, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000060546 | plasma protease C1 inhibitor sequence variant I462S, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000060388 | plasma protease C1 inhibitor sequence variant L177P, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000062857 | plasma protease C1 inhibitor sequence variant L481P, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061277 | plasma protease C1 inhibitor sequence variant L481R, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061573 | plasma protease C1 inhibitor sequence variant N291H, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061585 | plasma protease C1 inhibitor sequence variant P476L, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000063441 | plasma protease C1 inhibitor sequence variant P489R, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061680 | plasma protease C1 inhibitor sequence variant P498R, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000062491 | plasma protease C1 inhibitor sequence variant P498S, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000060429 | plasma protease C1 inhibitor sequence variant Q338*, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000062615 | plasma protease C1 inhibitor sequence variant Q474*, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061104 | plasma protease C1 inhibitor sequence variant Q484*, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000063530 | plasma protease C1 inhibitor sequence variant R400C, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061929 | plasma protease C1 inhibitor sequence variant R466C, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000064435 | plasma protease C1 inhibitor sequence variant R466H, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000064491 | plasma protease C1 inhibitor sequence variant R466L, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000062268 | plasma protease C1 inhibitor sequence variant R466S, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000062579 | plasma protease C1 inhibitor sequence variant R494*, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000063908 | plasma protease C1 inhibitor sequence variant S170P, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000063553 | plasma protease C1 inhibitor sequence variant S318*, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000063798 | plasma protease C1 inhibitor sequence variant T189N, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061036 | plasma protease C1 inhibitor sequence variant T467P, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000060501 | plasma protease C1 inhibitor sequence variant V288E, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000060960 | plasma protease C1 inhibitor sequence variant V473M, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000062324 | plasma protease C1 inhibitor sequence variant W482*, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061553 | plasma protease C1 inhibitor sequence variant Y496*, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000049210 | plasma protease C1 inhibitor, signal peptide removed form (human) | | | | | |
| |
| |
| | | | |
|
PR:P05155 | plasma protease C1 inhibitor (human) | | | | | |
| | | | | |
|
PR:000053466 | plasma protease C1 inhibitor N-glycosylated 1 (human) | | | | | |
| | | | | |
|
PR:000053475 | plasma protease C1 inhibitor N-glycosylated 10 (human) | | | | | |
| | | | | |
|
PR:000053476 | plasma protease C1 inhibitor N-glycosylated 11 (human) | | | | | |
| | | | | |
|
PR:000053477 | plasma protease C1 inhibitor N-glycosylated 12 (human) | | | | | |
| | | | | |
|
PR:000053478 | plasma protease C1 inhibitor N-glycosylated 13 (human) | | | | | |
| | | | | |
|
PR:000053479 | plasma protease C1 inhibitor N-glycosylated 14 (human) | | | | | |
| | | | | |
|
PR:000053480 | plasma protease C1 inhibitor N-glycosylated 15 (human) | | | | | |
| | | | | |
|
PR:000053481 | plasma protease C1 inhibitor N-glycosylated 16 (human) | | | | | |
| | | | | |
|
PR:000053482 | plasma protease C1 inhibitor N-glycosylated 17 (human) | | | | | |
| | | | | |
|
PR:000053483 | plasma protease C1 inhibitor N-glycosylated 18 (human) | | | | | |
| | | | | |
|
PR:000053484 | plasma protease C1 inhibitor N-glycosylated 19 (human) | | | | | |
| | | | | |
|
PR:000053467 | plasma protease C1 inhibitor N-glycosylated 2 (human) | | | | | |
| | | | | |
|
PR:000053485 | plasma protease C1 inhibitor N-glycosylated 20 (human) | | | | | |
| | | | | |
|
PR:000053486 | plasma protease C1 inhibitor N-glycosylated 21 (human) | | | | | |
| | | | | |
|
PR:000053487 | plasma protease C1 inhibitor N-glycosylated 22 (human) | | | | | |
| | | | | |
|
PR:000053488 | plasma protease C1 inhibitor N-glycosylated 23 (human) | | | | | |
| | | | | |
|
PR:000053468 | plasma protease C1 inhibitor N-glycosylated 3 (human) | | | | | |
| | | | | |
|
PR:000053469 | plasma protease C1 inhibitor N-glycosylated 4 (human) | | | | | |
| | | | | |
|
PR:000053470 | plasma protease C1 inhibitor N-glycosylated 5 (human) | | | | | |
| | | | | |
|
PR:000053471 | plasma protease C1 inhibitor N-glycosylated 6 (human) | | | | | |
| | | | | |
|
PR:000053472 | plasma protease C1 inhibitor N-glycosylated 7 (human) | | | | | |
| | | | | |
|
PR:000053473 | plasma protease C1 inhibitor N-glycosylated 8 (human) | | | | | |
| | | | | |
|
PR:000053474 | plasma protease C1 inhibitor N-glycosylated 9 (human) | | | | | |
| | | | | |
|
PR:000053489 | plasma protease C1 inhibitor O-glycosylated 1 (human) | | | | | |
| | | | | |
|
PR:000053498 | plasma protease C1 inhibitor O-glycosylated 10 (human) | | | | | |
| | | | | |
|
PR:000053499 | plasma protease C1 inhibitor O-glycosylated 11 (human) | | | | | |
| | | | | |
|
PR:000053500 | plasma protease C1 inhibitor O-glycosylated 12 (human) | | | | | |
| | | | | |
|
PR:000053501 | plasma protease C1 inhibitor O-glycosylated 13 (human) | | | | | |
| | | | | |
|
PR:000053502 | plasma protease C1 inhibitor O-glycosylated 14 (human) | | | | | |
| | | | | |
|
PR:000053503 | plasma protease C1 inhibitor O-glycosylated 15 (human) | | | | | |
| | | | | |
|
PR:000053504 | plasma protease C1 inhibitor O-glycosylated 16 (human) | | | | | |
| | | | | |
|
PR:000053505 | plasma protease C1 inhibitor O-glycosylated 17 (human) | | | | | |
| | | | | |
|
PR:000053490 | plasma protease C1 inhibitor O-glycosylated 2 (human) | | | | | |
| | | | | |
|
PR:000053491 | plasma protease C1 inhibitor O-glycosylated 3 (human) | | | | | |
| | | | | |
|
PR:000053492 | plasma protease C1 inhibitor O-glycosylated 4 (human) | | | | | |
| | | | | |
|
PR:000053493 | plasma protease C1 inhibitor O-glycosylated 5 (human) | | | | | |
| | | | | |
|
PR:000053494 | plasma protease C1 inhibitor O-glycosylated 6 (human) | | | | | |
| | | | | |
|
PR:000053495 | plasma protease C1 inhibitor O-glycosylated 7 (human) | | | | | |
| | | | | |
|
PR:000053496 | plasma protease C1 inhibitor O-glycosylated 8 (human) | | | | | |
| | | | | |
|
PR:000053497 | plasma protease C1 inhibitor O-glycosylated 9 (human) | | | | | |
| | | | | |
|
PR:000070326 | plasma protease C1 inhibitor deaminated 1 (human) | | | | | |
| | | | | |
|
PR:P05155-1 | plasma protease C1 inhibitor isoform h1 (human) | | | | | |
| | | | | |
|
PR:P05155-2 | plasma protease C1 inhibitor isoform h2 (human) | | | | | |
| | | | | |
|
PR:P05155-3 | plasma protease C1 inhibitor isoform h3 (human) | | | | | |
| | | | | |
|
PR:000060408 | plasma protease C1 inhibitor sequence variant A456E, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000062279 | plasma protease C1 inhibitor sequence variant A458T, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061318 | plasma protease C1 inhibitor sequence variant A458V, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000060778 | plasma protease C1 inhibitor sequence variant F225*, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061855 | plasma protease C1 inhibitor sequence variant F236S, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000064313 | plasma protease C1 inhibitor sequence variant G184E, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061662 | plasma protease C1 inhibitor sequence variant G184R, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000062550 | plasma protease C1 inhibitor sequence variant G345R, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000064158 | plasma protease C1 inhibitor sequence variant G493E, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061229 | plasma protease C1 inhibitor sequence variant G493R, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061510 | plasma protease C1 inhibitor sequence variant I196N, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000060546 | plasma protease C1 inhibitor sequence variant I462S, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000060388 | plasma protease C1 inhibitor sequence variant L177P, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000062857 | plasma protease C1 inhibitor sequence variant L481P, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061277 | plasma protease C1 inhibitor sequence variant L481R, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061573 | plasma protease C1 inhibitor sequence variant N291H, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061585 | plasma protease C1 inhibitor sequence variant P476L, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000063441 | plasma protease C1 inhibitor sequence variant P489R, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061680 | plasma protease C1 inhibitor sequence variant P498R, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000062491 | plasma protease C1 inhibitor sequence variant P498S, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000060429 | plasma protease C1 inhibitor sequence variant Q338*, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000062615 | plasma protease C1 inhibitor sequence variant Q474*, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061104 | plasma protease C1 inhibitor sequence variant Q484*, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000063530 | plasma protease C1 inhibitor sequence variant R400C, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061929 | plasma protease C1 inhibitor sequence variant R466C, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000064435 | plasma protease C1 inhibitor sequence variant R466H, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000064491 | plasma protease C1 inhibitor sequence variant R466L, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000062268 | plasma protease C1 inhibitor sequence variant R466S, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000062579 | plasma protease C1 inhibitor sequence variant R494*, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000063908 | plasma protease C1 inhibitor sequence variant S170P, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000063553 | plasma protease C1 inhibitor sequence variant S318*, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000063798 | plasma protease C1 inhibitor sequence variant T189N, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061036 | plasma protease C1 inhibitor sequence variant T467P, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000060501 | plasma protease C1 inhibitor sequence variant V288E, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000060960 | plasma protease C1 inhibitor sequence variant V473M, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000062324 | plasma protease C1 inhibitor sequence variant W482*, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000061553 | plasma protease C1 inhibitor sequence variant Y496*, signal peptide removed form (human) | | | | | |
| | | | | |
|
PR:000049210 | plasma protease C1 inhibitor, signal peptide removed form (human) | | | | | |